Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life
Journal of Clinical Oncology · 01.07.2023 · 41 (19) · 3512-3522
DOI: 10.1200/jco.22.01016 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 01.07.2023. Verfasst von Sjoukje Lubberts und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Testicular Neoplasms, Dyslipidemias. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE Testicular cancer (TC) treatment is clearly associated with cardiovascular morbidity and mortality. To enable development of preventive strategies for cardiovascular disease (CVD), we assessed cardiometabolic risk factors and quality of life (QoL) in TC survivors. METHODS Incidence of coronary artery disease, myocardial infarction, and heart failure after TC treatment was assessed in a multicenter cohort comprising 4,748 patients treated at the age of 12-50 years between 1976 and 2007. Patients who had developed CVD and a random sample from the cohort (subcohort) received a questionnaire on cardiometabolic risk factors and QoL. A subgroup of responders in the subcohort additionally underwent clinical evaluation of cardiovascular risk factors. RESULTS After a median follow-up of 16 years, 272 patients had developed CVD. Compared with orchidectomy only, cisplatin combination chemotherapy was associated with an increased CVD risk (hazard ratio [HR], 1.9; 95% CI, 1.1 to 3.1). Patients who were obese or a smoker at diagnosis (HR, 4.6; 95% CI, 2.0 to 10.0 and HR, 1.7; 95% CI, 1.1 to 2.4, respectively), developed Raynaud's phenomenon (HR, 1.9; 95% CI, 1.1 to 3.6) or dyslipidemia (HR, 2.8; 95% CI, 1.6 to 4.7) or had a positive family history for CVD (HR, 2.9; 95% CI, 1.7 to 4.9) had higher CVD risk. More TC survivors with CVD reported inferior QoL on physical domains than survivors who did not develop CVD. Of 304 TC survivors who underwent clinical evaluation for cardiovascular risk factors (median age at assessment: 51 years), 86% had dyslipidemia, 50% had hypertension, and 35% had metabolic syndrome, irrespective of treatment. CONCLUSION Cardiovascular events in TC survivors impair QoL. Many TC survivors have undetected cardiovascular risk factors. We advocate early lifestyle adjustments and lifelong follow-up with low-threshold treatment of cardiovascular risk factors, especially in obese and smoking patients treated with platinum-based chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.
- Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
ORCID-Profile: Harmke J Groot, Sasja Mulder, Gerard Groenewegen, Flora E van Leeuwen, Michael Schaapveld, Jourik A Gietema
Zitieren
APA
Lubberts, S., Groot, H. J., de Wit, R., Mulder, S., Witjes, J. A., Kerst, J. M., Groenewegen, G., Lefrandt, J. D., van Leeuwen, F. E., Nuver, J., Schaapveld, M., & Gietema, J. A. (2023). Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life. Journal of Clinical Oncology, 41(19), 3512-3522. https://doi.org/10.1200/jco.22.01016
Vancouver
Lubberts S, Groot HJ, de Wit R, Mulder S, Witjes JA, Kerst JM, et al. Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life. Journal of Clinical Oncology. 2023;41(19):3512-3522. doi:10.1200/jco.22.01016
BibTeX
@article{Lubberts2023,
author = {Lubberts, Sjoukje and Groot, Harmke J and de Wit, Ronald and Mulder, Sasja and Witjes, Johannes A and Kerst, J Martijn and Groenewegen, Gerard and Lefrandt, Joop D and van Leeuwen, Flora E and Nuver, Janine and Schaapveld, Michael and Gietema, Jourik A},
title = {Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {19},
pages = {3512--3522},
doi = {10.1200/jco.22.01016}
}
EUVIMED